Better Access. Better Healthcare
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
About Abacus Medicine Group teaser ullamcorper iaculis lectus sed vel dui
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce quis lectus quis sem lacinia nonummy. Proin mollis lorem non dolor. In hac habitasse platea dictumst. Nulla ultrices odio.
Nunc urna ligula, gravida a, pretium vitae, bibendum nec, ante. Aliquam ullamcorper iaculis lectus. Sed vel dui. Etiam lacinia risus vitae lacus. Aliquam elementum imperdiet turpis. Bibendum nec, ante. Aliquam ullamcorper iaculis lectus. Sed vel dui. Etiam lacinia risus.
Flemming Wagner
CEO & majority shareholder
Global locations
Employees
Millions packs sold
Be a part of Abacus Medicine Group
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Fusce quis lectus quis sem lacinia nonummy. Proin mollis lorem non dolor. In hac habitasse platea dictumst. Nulla ultrices odio…
Latest news
Sustainability Report 2022: The Abacus Medicine Group continued to work with sustainability and ESG within 6 focus programs
A materiality assessment, an official Diversity & Inclusion strategy, and workshops for increased awareness of sustainability and ESG across the company were among the concrete initiatives in the Group’s strategic sustainability efforts.
Annual Report 2022: Profitability focus pays off for the Abacus Medicine Group
Increasing profitability was a declared target for the Group for 2022 and this was successfully achieved. Based on strong performance especially in the parallel distribution business EBITDA grew 58% to a record level of EUR 26.2 million.
Milestone: 1,000,000,000 euros
The Abacus Medicine Group has reached another major milestone. Today, the combined revenue of the group’s business units has surpassed 1,000,000,000 euros for the first time.